Clinical Trials Logo

Skin Aging clinical trials

View clinical trials related to Skin Aging.

Filter by:

NCT ID: NCT00884936 Completed - Skin Aging Clinical Trials

Identification of Gene Biomarkers in Aging Skin

Start date: August 2008
Phase: N/A
Study type: Observational

This study is a blinded, prospective, single-center, clinical study conducted in Japanese female subjects between the ages of 20-75 years. This design uses skin biopsy samples from environmentally exposed areas and unexposed (control) areas within the same subjects to assess the gene expression profile from three different age groups.

NCT ID: NCT00856414 Completed - Skin Aging Clinical Trials

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Start date: March 2009
Phase: Phase 4
Study type: Interventional

This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

NCT ID: NCT00818311 Completed - Skin Aging Clinical Trials

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Start date: June 2008
Phase: N/A
Study type: Interventional

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose light emitting diode (LED) array for improving the appearance of photo aging damage. The photomodulation concept includes a low energy, narrow band or coherent light with specific pulse sequences and durations. Preliminary investigations done by McDaniel et al. demonstrated that fibroblast activity could be regulated using pulsing light at specific wavelenghts. Using a variety of LED light sources, his group has demonstrated that by varying light pulses and other parameters, procollagen synthesis could be upregulated in human skin fibroblast culture [McDaniel DH, et al.Lasers Surg Med. 2002; 14-251]. A clinical correlation was also shown based on different clinical trials data on around 1000 subjects, LED has shown up to 90% improvement in wrinkles and an increase of collagen synthesis versus control with little or no side effects associated [Weiss, RA et al. Lasers Surg Med 2005; 36(2): 85-91- Weiss, RA et al.: J Drugs Dermatol 2004; 3(6): 605-610 - Weiss RA et al. Dermatol Surg 2005; 31(9):1999-1204 - Russel BA et al. J Cosmet Laser Ther 2005; 7 (3-4):196-200 - Bhat J et al. Laser Med Sci 2005; 20(1):6-10]. Based on these promising clinical data, Light BioScience submitted a dossier to the Food and Drug Administration (FDA) and obtained in January 2005 the FDA approval for its GentleWaves® Light Emitting Diode (LED) for the non-invasive treatment of periorbital (eye area) wrinkles and rhytids. The LED technology has been considered by FDA as non significant risk. In Europe, the GentleWaves® Light Emitting Diode has obtained the notified body certification for the same indication. This medical claim is associated with cosmetic improvement of aging and sun-damaged skin, further validation the science of LED photomodulation skin rejuvenation [Investigator's Brochure. Version 1]. This approval has been obtained with a professional LED GentleWaves® device used under a physician's responsibility. The initial regimen of 35 seconds twice per week with at least two days in between treatment for a total of 4 weeks duration of treatment has demonstrated efficacy for the treatment of typical signs of photo aging and no adverse effect. A monocentre, randomized clinical study.

NCT ID: NCT00818246 Completed - Skin Aging Clinical Trials

Light Emitting Diode (LED) for the Treatment of Wrinkles

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study was to determine whether light emitting diode (LED) therapy can improve skin appearance of human subjects with aged/photoaged skin. A reduction in rhytid depth as well as in skin surface roughness and in the degree of elastosis after LED treatments was expected.

NCT ID: NCT00767156 Not yet recruiting - Skin Aging Clinical Trials

Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging

SBanti-aging
Start date: October 2008
Phase: N/A
Study type: Interventional

The effect of oral supplementation of SBA24 sea buckthorn oil capsule and topical application of Omega7 sea buckthorn cream on skin ageing is studied in a single blind, parallel study.

NCT ID: NCT00766376 Active, not recruiting - Skin Aging Clinical Trials

Safety and Efficacy Evaluation of Erbium Treatment

Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the safety and effectiveness of erbium lasers for dermatological cosmetic procedures.

NCT ID: NCT00761878 Completed - Skin Aging Clinical Trials

Evaluation of the PlasmaJet Neutral Argon Plasma System to Treat Skin Ageing

Start date: December 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the comparative effects of the PlasmaJet neutral argon plasma system and the Rhytec Portrait PRS nitrogen plasma system in the treatment of aging facial skin

NCT ID: NCT00629317 Completed - Skin Aging Clinical Trials

Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage

Start date: February 2008
Phase: Phase 3
Study type: Interventional

The aim of the study is to determine the efficacy of MAL + Aktilite versus placebo + Aktilite in facial photodamage in a randomized double blind trial.

NCT ID: NCT00492479 Terminated - Skin Aging Clinical Trials

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Start date: June 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

NCT ID: NCT00447551 Completed - Skin Aging Clinical Trials

Canadian Aesthetic Experience With Sculptra Therapy

Start date: January 2007
Phase: Phase 4
Study type: Interventional

Primary objective To evaluate the degree of correction achievable with Sculptra for nasolabial folds, mid- and lower facial volume loss, jawline laxity and other signs of facial ageing. To document the types and incidence of device-related adverse events with Sculptra.